Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS - A Novel Therapeutic Opportunity.

Research output: Contribution to journalArticle

Abstract

ClinicalTrials.gov NCT01802697.

Details

Authors
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Pharmaceutical Sciences
Original languageEnglish
Article numbere0132011
JournalPLoS ONE
Volume10
Issue number7
Publication statusPublished - 2015
Publication categoryResearch
Peer-reviewedYes